Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry
- 1 July 2021
- journal article
- research article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 89, 65-75
Abstract
No abstract availableKeywords
Funding Information
- European Society of Cardiology
This publication has 38 references indexed in Scilit:
- Changes in Uric Acid Levels and Allopurinol Use in Chronic Heart Failure: Association With Improved SurvivalJournal of Cardiac Failure, 2012
- Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological dataEuropean Heart Journal, 2011
- Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failureAmerican Heart Journal, 2010
- Impact of Oxypurinol in Patients With Symptomatic Heart FailureJACC, 2008
- Assessing Kidney Function — Measured and Estimated Glomerular Filtration RateNew England Journal of Medicine, 2006
- The Seattle Heart Failure ModelCirculation, 2006
- Neurohumoral Pathways in Heart Failure With Preserved Systolic FunctionProgress in Cardiovascular Diseases, 2005
- Uric Acid and Survival in Chronic Heart FailureCirculation, 2003
- Vascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart FailureCirculation, 2002
- Enhanced Expression and Activity of Xanthine Oxidoreductase in the Failing HeartJournal of Molecular and Cellular Cardiology, 2000